Video
Chris Topoleski, director of federal regulatory affairs for ASHP, outlines the immediate impacts that achieving provider status would likely have on health-system pharmacists' practice.
Chris Topoleski, director of federal regulatory affairs for ASHP, outlines the immediate impacts that achieving provider status would likely have on health-system pharmacists' practice.
This video was recorded at ASHP's Summer Meeting and Exposition in June 2015.